{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:55:08Z","timestamp":1790294108507,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pregnancy-associated breast cancer (PABC) is a complex condition affecting 1 in 3000 pregnancies worldwide. While clinical management has improved, the optimal staging approach for PABC remains uncertain. <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose PET (FDG-PET) imaging is a standard diagnostic tool for many cancers. However, its use in PABC staging is controversial due to potential radiation risks to the foetus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective case series analysed clinical data from six patients with high-risk PABC who underwent FDG-PET imaging for staging between 2022 and 2023. FDG-PET was based on locally implemented ultra-low-dose imaging protocols. The radiation doses to the foetus were dosimetrically estimated based on dose-per-unit activity values and correlated with postpartum neonatal outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median foetal radiation dose was 0.975 mGy (range 0.6\u20131.5 mGy) and was below the threshold for deterministic toxicities. PET imaging upstaged nodal involvement in 33% of patients and influenced treatment decisions. FDG-PET imaging provided valuable staging information in all cases. No adverse foetal effects were observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Ultra-low-dose FDG-PET imaging is a valuable tool providing accurate staging information to guide treatment decisions. The low radiation dose associated with this technique makes it a clinically acceptable modality for cancer staging in pregnant women. A larger case series is needed to precisely quantify foetal radiation doses and assess long-term safety.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mnm.0000000000001997","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T06:00:10Z","timestamp":1749016810000},"page":"772-779","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The safety and clinical impact of ultra-low-dose FDG-PET imaging in pregnancy-associated breast cancer: the experience of a major tertiary oncology referral centre in the UK and suggested imaging protocol"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3831-0165","authenticated-orcid":false,"given":"Karen","family":"Desouza","sequence":"first","affiliation":[{"name":"Cancer Division, Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH)"},{"name":"Surgery and Cancer Integrated Clinical Service Unit, Whittington Health NHS Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Fessas","sequence":"additional","affiliation":[{"name":"Cancer Division, Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Spurrell","sequence":"additional","affiliation":[{"name":"Surgery and Cancer Integrated Clinical Service Unit, Whittington Health NHS Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Papadimitraki","sequence":"additional","affiliation":[{"name":"Cancer Division, Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fharat","family":"Raja","sequence":"additional","affiliation":[{"name":"Cancer Division, Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Roylance","sequence":"additional","affiliation":[{"name":"Cancer Division, Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ottaviani","sequence":"additional","affiliation":[{"name":"Cancer Division, Department of Oncology, University College London Hospitals NHS Foundation Trust (UCLH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Franks","sequence":"additional","affiliation":[{"name":"Department of Oncoplastic Breast Surgery, Women\u2019s Health Division, UCLH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibendu","family":"Betal","sequence":"additional","affiliation":[{"name":"Department of Oncoplastic Breast Surgery, Women\u2019s Health Division, UCLH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahwash","family":"Babar","sequence":"additional","affiliation":[{"name":"Surgery and Cancer Integrated Clinical Service Unit, Whittington Health NHS Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Athanasiou","sequence":"additional","affiliation":[{"name":"Surgery and Cancer Integrated Clinical Service Unit, Whittington Health NHS Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimilano","family":"Cariati","sequence":"additional","affiliation":[{"name":"Department of Oncoplastic Breast Surgery, Women\u2019s Health Division, UCLH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill","family":"Patani","sequence":"additional","affiliation":[{"name":"Department of Oncoplastic Breast Surgery, Women\u2019s Health Division, UCLH"},{"name":"Institute of Women\u2019s Health, University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirwan","family":"Hadad","sequence":"additional","affiliation":[{"name":"Surgery and Cancer Integrated Clinical Service Unit, Whittington Health NHS Trust"},{"name":"Department of Oncoplastic Breast Surgery, Women\u2019s Health Division, UCLH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Kayani","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, UCLH, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Walls","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, UCLH, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Scott","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, UCLH, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Rega","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, UCLH, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarik","family":"Arshad","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, UCLH, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshed","family":"Bomanji","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, UCLH, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"V\u00f6\u00f6","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, UCLH, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"R1-20250709","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bpobgyn.2022.05.001","article-title":"Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities.","volume":"82","author":"Boere","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R2-20250709","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF02305802","article-title":"Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger.","volume":"3","author":"Anderson","year":"1996","journal-title":"Ann Surg Oncol"},{"key":"R3-20250709","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jmwh.2008.12.007","article-title":"Pregnancy-associated breast cancer: significance of early detection.","volume":"54","author":"Ulery","year":"2009","journal-title":"J Midwifery Womens Health"},{"key":"R4-20250709","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(11)61092-1","article-title":"Breast cancer in pregnancy.","volume":"379","author":"Amant","year":"2012","journal-title":"Lancet"},{"key":"R5-20250709","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1200\/JCO.2016.69.9439","article-title":"Maternal cancer during pregnancy and risks of stillbirth and infant mortality.","volume":"35","author":"Lu","year":"2017","journal-title":"J Clin Oncol"},{"key":"R6-20250709","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.mayocpiqo.2024.02.002","article-title":"Pregnancy-associated cancer: a systematic review and meta-analysis.","volume":"8","author":"Walters","year":"2024","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"R7-20250709","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1470-2045(18)30059-7","article-title":"Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients.","volume":"19","author":"de Haan","year":"2018","journal-title":"Lancet Oncol"},{"key":"R8-20250709","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejca.2022.04.014","article-title":"Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls.","volume":"170","author":"Amant","year":"2022","journal-title":"Eur J Cancer"},{"key":"R9-20250709","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamaoncol.2015.2413","article-title":"Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients.","volume":"1","author":"Loibl","year":"2015","journal-title":"JAMA Oncol"},{"key":"R10-20250709","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.breast.2017.07.014","article-title":"Whole body MRI for systemic staging of breast cancer in pregnant women.","volume":"35","author":"Peccatori","year":"2017","journal-title":"Breast"},{"key":"R11-20250709","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.acra.2016.11.015","article-title":"Incremental cancer detection of locoregional restaging with diagnostic mammography combined with whole-breast and regional nodal ultrasound in women with newly diagnosed breast cancer.","volume":"24","author":"Candelaria","year":"2017","journal-title":"Acad Radiol"},{"key":"R12-20250709","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1148\/radiol.2019190563","article-title":"First-trimester exposure to gadolinium-based contrast agents: a utilization study of 4.6 million U.S. pregnancies.","volume":"293","author":"Bird","year":"2019","journal-title":"Radiology"},{"key":"R13-20250709","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/annonc\/mdz189","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"R15-20250709","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s00259-024-06694-x","article-title":"Joint EANM-SNMMI guidelines on the role of 2-[(18)F]FDG PET\/CT in no special type breast cancer: differences and agreements with European and American guidelines.","volume":"51","author":"Groheux","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-20250709","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"key":"R17-20250709","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cpet.2023.12.002","article-title":"Quarter-century transformation of oncology: positron emission tomography for patients with breast cancer.","volume":"19","author":"Ulaner","year":"2024","journal-title":"PET Clin"},{"key":"R19-20250709","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2967\/jnumed.107.048900","article-title":"Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy.","volume":"49","author":"Zanotti-Fregonara","year":"2008","journal-title":"J Nucl Med"},{"key":"R20-20250709","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2967\/jnumed.109.071878","article-title":"Absorbed 18F-FDG dose to the fetus during early pregnancy.","volume":"51","author":"Zanotti-Fregonara","year":"2010","journal-title":"J Nucl Med"},{"key":"R21-20250709","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/RLU.0b013e3182478a91","article-title":"FDG PET\/CT of a late-term pregnant woman with breast cancer.","volume":"37","author":"Hsieh","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R22-20250709","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2967\/jnumed.115.157032","article-title":"Fetal radiation dose from 18F-FDG in pregnant patients imaged with PET, PET\/CT, and PET\/MR.","volume":"56","author":"Zanotti-Fregonara","year":"2015","journal-title":"J Nucl Med"},{"key":"R23-20250709","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2967\/jnumed.117.195404","article-title":"New fetal radiation doses for (18)F-FDG based on human data.","volume":"58","author":"Zanotti-Fregonara","year":"2017","journal-title":"J Nucl Med"},{"key":"R24-20250709","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/0284186X.2021.2004323","article-title":"Feasibility, safety and impact of (18F)-FDG PET\/CT in patients with pregnancy-associated cancer: experience of the French CALG (Cancer Associe a La Grossesse) network.","volume":"61","author":"Despierres","year":"2022","journal-title":"Acta Oncol"},{"key":"R25-20250709","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/diagnostics13010028","article-title":"Long axial field-of-view PET for ultra-low-dose imaging of non-hodgkin lymphoma during pregnancy.","volume":"13","author":"van Sluis","year":"2023","journal-title":"Diagnostics"},{"key":"R26-20250709","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40658-024-00648-w","article-title":"Ultra-low foetal radiation exposure in 18F-FDG PET\/CT imaging with a long axial field-of-view PET\/CT system.","volume":"11","author":"Smith","year":"2024","journal-title":"EJNMMI Physics"},{"key":"R27-20250709","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/AOG.0000000000001316","article-title":"Committee Opinion No. 656: guidelines for diagnostic imaging during pregnancy and lactation.","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R29-20250709","doi-asserted-by":"crossref","first-page":"1948; author reply 1949","DOI":"10.1016\/S0140-6736(12)60851-4","article-title":"Pregnancy should not rule out 18FDG PET\/CT for women with cancer.","volume":"379","author":"Zanotti-Fregonara","year":"2012","journal-title":"Lancet"},{"key":"R30-20250709","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00259-023-06406-x","article-title":"International EANM-SNMMI-ISMRM consensus recommendation for PET\/MRI in oncology.","volume":"50","author":"Veit-Haibach","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R31-20250709","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0.","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R32-20250709","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2967\/jnumed.110.085381","article-title":"18F-FDG PET in pregnancy and fetal radiation dose estimates.","volume":"52","author":"Takalkar","year":"2011","journal-title":"J Nucl Med"},{"key":"R33-20250709","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.semnuclmed.2014.06.003","article-title":"Radiation dose concerns for the pregnant or lactating patient.","volume":"44","author":"Stabin","year":"2014","journal-title":"Semin Nucl Med"},{"key":"R35-20250709","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/0955300031000114729","article-title":"Risk coefficients for childhood cancer after intrauterine irradiation: a review.","volume":"79","author":"Wakeford","year":"2003","journal-title":"Int J Radiat Biol"},{"key":"R36-20250709","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/diagnostics13010028","article-title":"Long axial field-of-view PET for ultra-low-dose imaging of non-hodgkin lymphoma during pregnancy.","volume":"13","author":"van Sluis","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R37-20250709","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00259-022-06076-1","article-title":"Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET\/CT.","volume":"50","author":"Korsholm","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R38-20250709","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1753495X17724950","article-title":"The use of PET\/CT in pregnancy: a case report of malignant parathyroid carcinoma and a review of the literature.","volume":"11","author":"Gill","year":"2018","journal-title":"Obstet Med"},{"key":"R39-20250709","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1097\/RLU.0000000000003045","article-title":"FDG PET\/CT in a pregnant woman with breast cancer.","volume":"45","author":"Drouet","year":"2020","journal-title":"Clin Nucl Med"},{"key":"R40-20250709","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/RLU.0000000000002663","article-title":"18F-FDG whole-body PET\/MRI of a 30-week pregnant woman with breast cancer revealed interesting fetal findings.","volume":"44","author":"Blanc-Durand","year":"2019","journal-title":"Clin Nucl Med"},{"key":"R41-20250709","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.3390\/jcm11133820","article-title":"Use of positron emission tomography for pregnancy-associated cancer assessment: a review.","volume":"11","author":"Parpinel","year":"2022","journal-title":"J Clin Med"},{"issue":"Suppl 6","key":"R42-20250709","doi-asserted-by":"crossref","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","article-title":"Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"24","author":"Peccatori","year":"2013","journal-title":"Ann Oncol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T12:00:56Z","timestamp":1752062456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000001997","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}